STUDresearch · Peptide
Thymogen
Also known as
Thymogen peptide · Glu-Trp dipeptide · EW dipeptide
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Niche talk
Systemic
IM / Intranasal / SubQ / Oral
Organ bioregulators
Systemic immune-modulation discussion around a defined Glu-Trp dipeptide; route and product form vary.
What people say
Thymogen is the defined Glu-Trp dipeptide, also called oglufanide. It came from work on Thymalin but is not that extract, TA1, thymopentin or thymulin.
Doses people talk about
IM, intranasal, oral and gray-market SubQ forms cannot be assumed bioequivalent, and the rat radiolabel dose is not a human amount row.
How it may feel
One reporter described early benefit plus water retention and severe constipation, then later said only a much higher self-selected amount helped and hormonal symptoms led back to TA1. This is one unverified product account.
Legacy product-chart amount~100 mcg per administration
A preserved multi-day product range whose exact route and frequency depend on the registered formulation.
Single-person SubQ report~1.6 mg SubQ daily
The reporter later said lower amounts did nothing and this amount felt helpful but caused uncomfortable hormonal symptoms; it is not a dose recommendation.
Half-life & effect duration
- Half-life in the body
- Intact parent peptideNo settled estimate
- Felt duration people report
- One evolving accountLess malaise or throat discomfort, alongside water retention and constipation
- Later updateBenefit depended on amount; hormonal symptoms prompted a return to another peptide
Cycles people discuss
Short multi-day courses and seasonal repeats dominate the preserved product culture. The inspected self-report instead changed amount over time and does not establish a reusable course.
Timing
The retained community notes consider tolerability, training and sleep without establishing a Thymogen-specific morning, evening or meal rule. The rat radiolabel sampling times do not supply a human dosing clock.
Stacks
It is discussed beside other bioregulators and TA1, but the clearest reviewed account compared rather than cleanly combined them. Multi-agent use would make attribution worse.
Watch for
Observed adverse course: One SubQ reporter described substantial water retention and severe constipation after a week, then later reported uncomfortable hormonal symptoms at about 1.6 mg/day and returned to TA1; product identity and causality remain unverified.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
No human intact-parent elimination half-life was established.
In rats given 870 µg/kg IM radiolabeled Glu-Trp, plasma radioactivity peaked at 1–2 hours and about 85% of administered radioactivity was excreted by 24 hours.
The assay measured radioactivity after basic hydrolysis, not intact Thymogen; it was an animal IM study and cannot supply human SubQ, oral or intranasal parent kinetics.
- Morozov and Khavinson: Natural and synthetic thymic peptides as therapeutics for immune dysfunction (opens in a new tab)Full five-page paper inspected; PDF page 2, Pharmacokinetic Study: rats received 870 µg/kg IM tritium-labeled Glu-Trp, plasma radioactivity peaked at 1–2 hours, and about 85% of administered radioactivity was excreted within 24 hours. Page 1 defines Thymogen as synthetic Glu-Trp derived from a Thymalin fraction.Originator-line study in rats using radiolabel and hydrolyzed samples; it does not identify intact-parent concentration, a half-life, human kinetics or cross-route bioequivalence.
Felt duration people report
One same-author report changed from early benefit and side effects to dose-dependent benefit, hormonal symptoms and a return to TA1; no dependable per-dose window emerged.
The person described one week of SubQ use, less malaise and mouth/throat discomfort, water retention and severe constipation, then later said lower amounts did not help and about 1.6 mg/day brought both benefit and hormonal symptoms.
Single self-reporter, unverified Russian product, non-labeled route, changing amount and chronic MCAS context; no blinded control or pharmacokinetic measurement.
- Thymogen alpha-1 (opens in a new tab)Complete visible thread and follow-ups inspected. MouseGraft distinguished the oral blend discussed by the original poster from Russian Glu-Trp Thymogen, reported one-week SubQ benefit with water retention and severe constipation, and later reported that lower amounts did not help, about 1.6 mg/day helped but caused hormonal symptoms, and TA1 was resumed.Single unverified-product account with chronic illness and self-selected off-label route; the original poster used a different oral combination product, so their responses were not merged.
What people say
- immune narrative: Community and regional literature frame benefits around immune function and “normalization” language. forum
- What is thinner: Large modern multi-center RCTs are often absent for the specific peptide brand story. forum
- Organ-target lore: Thymogen is sold in Khavinson-style catalogs for a specific organ/system story rather than a systemic “GH peptide” narrative. forum
- Course culture: Users often describe multi-day to multi-week capsule courses, then breaks — more “seasonal tune-up” than daily forever. forum
- Subtlety claims: Benefits, when claimed, are usually mild (comfort, “support,” recovery feel) and hard to separate from sleep/diet. anecdote
Doses people talk about
- Common course talk: often ~100 mcg class doses (product form dependent) for multi-day courses — IM/intranasal product lines differ. forum
- Course length: frequently 5–10 day courses in bioregulator-style writeups, sometimes repeated seasonally. forum
- Honesty: exact mcg depends on registered product form; research-chem “thymogen” labels vary. forum
- Framing: Russian thymic peptide product culture (Glutamyl-Tryptophan / Thymogen). trialforum
How it may feel
- One week to later follow-up: One person using a Russian Thymogen product SubQ reported less food-triggered malaise and mouth/throat discomfort after a week, plus water retention and severe constipation. In a later same-author update, lower amounts had not helped; about 1.6 mg/day felt helpful but brought uncomfortable hormonal symptoms, so the person returned to TA1. anecdote
- Courses: Often 10–20 day courses repeated a few times per year in bioregulator culture. forum
- Day 1: Most people notice logistics (route, sting, GI) more than a “miracle” effect from Thymogen. forum
- Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
- Weeks 1–2: First honest checkpoint in self-logs. forum
Cycles people discuss
- Course culture: Short on, long off, repeat seasonally is the common pattern. forum
- Common pattern: Many self-protocols use weeks-on / weeks-off rather than indefinite daily use — cost and caution drive this more than hard science. forum
- No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
- Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum
Timing
- Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
- PK honesty: Thymogen bioregulator products rarely publish rigorous human PK packages in English literature. forum
- Rat radiolabel study, not a human half-life: After 870 µg/kg IM radiolabeled Glu-Trp, plasma radioactivity peaked at about 1–2 hours and about 85% of administered radioactivity was excreted within 24 hours. Hydrolyzed-sample radioactivity does not establish intact-parent clearance. animal
More on what it is
- Evidence honesty: Much of the English-web discussion is secondary summaries and vendor literature; treat claims cautiously. forum
- Research posture: Educational summary of public discussion and literature themes only. forum
- How people talk about it: Forum volume is a popularity signal for Thymogen, not proof it works for you. forum
- What it is: Thymogen is the synthetic Glu-Trp dipeptide also called oglufanide, developed from a molecule isolated from the multi-peptide thymus extract Thymalin. It is not thymosin alpha-1, thymulin or an interchangeable thymus blend. trial
- Research only: Not approved advice for self-experimentation; legality and access vary by place. forum
Stacks
- Multi-bioregulator stacks: Often combined by organ system in protocols. forum
- Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Observed adverse course: One SubQ reporter described substantial water retention and severe constipation after a week, then later reported uncomfortable hormonal symptoms at about 1.6 mg/day and returned to TA1; product identity and causality remain unverified. anecdote
- Allergy / unknown impurities: Gray-market risk. forum
- Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
- Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
- Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
- Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.